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Nitric-oxide synthases (NOSs)2 are bidomain enzymes, with
an N-terminal heme or oxygenase domain and a C-terminal
flavin or reductase domain connected by a calmodulin (CaM)
binding region. These enzymes catalyze the conversion of L-arginine to nitric oxide (NO) and L-citrulline in a series of two
monooxygenase reactions (1, 2). Upon binding of Ca2⫹/CaM,
electrons donated by NADPH are passed through the reductase
domain to the heme domain, where NO is formed. NO plays an
important role in both the physiology and pathology of many
organisms, including humans (3). NO is produced in a cell- and
tissue-specific manner by three different isoforms, namely neuronal NOS (nNOS), endothelial NOS (eNOS) and inducible
NOS (iNOS), which are encoded by three different genes. Both
nNOS and eNOS are expressed constitutively, whereas iNOS
expression is regulated at the transcriptional level by cytokines
and interleukins. An influx of calcium into the cell is necessary
for CaM to bind to constitutive NOSs, whereas it is tightly
bound to iNOS (4). The rates of electron transfer and NO production vary among the three isoforms.
Crystal structures of the heme domain dimers of nNOS (5, 6),
eNOS (7, 8), and iNOS (8, 9) have been solved. All three
enzymes showed a similar ␣/␤ fold with a single zinc atom per
dimer (7, 8), and all maintained similar topologies of binding for
substrate and cofactors. So far, no substantial difference has
been found among the heme domains that can explain the variance among the activities of NOS isoforms. The reductase
domains of all NOSs bear ⬃50 – 60% sequence similarity with
NADPH-cytochrome P450 oxidoreductase (CYPOR) (10). Primary sequence comparison revealed the presence of a stretch of
⬃45 amino acids in the FMN binding domain of constitutive
NOSs that is absent in iNOS and CYPOR (11). This stretch of
amino acids, known as the autoregulatory insert, regulates the
flow of electrons in a Ca2⫹/CaM-dependent manner. The
C-terminal ends of all three isoforms, which are absent in
CYPOR, are also calmodulin-modulated regulatory regions
(12–15). These C-terminal tails negatively modulate the flow of
electrons through the reductase domain in the absence of
2

The abbreviations used are: NOS, nitric-oxide synthase; nNOS, neuronal
nitric-oxide synthase; eNOS, endothelial nitric-oxide synthase; iNOS,
inducible nitric-oxide synthase; NO, nitric oxide; CaM, calmodulin; CYPOR,
cytochrome P450 oxidoreductase.
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The crystal structure of the neuronal nitric-oxide synthase
(nNOS) NADPH/FAD binding domain indicated that Ser-1176 is
within hydrogen bonding distance of Asp-1393 and the O4 atom of
FAD and is also near the N5 atom of FAD (3.7 Å). This serine residue is conserved in most of the ferredoxin-NADPⴙ reductase family of proteins and is important in electron transfer. In the present
study, the homologous serines of both nNOS (Ser-1176) and endothelial nitric-oxide synthase (eNOS) (Ser-942) were mutated to
threonine and alanine. Both substitutions yielded proteins that
exhibited decreased rates of electron transfer through the flavin
domains, in the presence and absence of Ca2ⴙ/CaM, as measured
by reduction of potassium ferricyanide and cytochrome c. Rapid
kinetics measurements of flavin reduction of all the mutants also
showed a decrease in the rate of flavin reduction, in the absence and
presence of Ca2ⴙ/CaM, as compared with the wild type proteins.
The serine to alanine substitution caused both nNOS and eNOS to
synthesize NO more slowly; however, the threonine mutants gave
equal or slightly higher rates of NO production compared with the
wild type enzymes. The midpoint redox potential measurements of
all the redox centers revealed that wild type and threonine mutants
of both nNOS and eNOS are very similar. However, the redox
potentials of the FMN/FMNH䡠 couple for alanine substitutions of
both nNOS and eNOS are >100 mV higher than those of wild type
proteins and are positive. These data presented here suggest that
hydrogen bonding of the hydroxyl group of serine or threonine
with the isoalloxazine ring of FAD and with the amino acids in its
immediate milieu, particularly nNOS Asp-1393, affects the redox
potentials of various flavin states, influencing the rate of electron
transfer.

Role of Conserved Serine in Constitutive NOS Isoforms

EXPERIMENTAL PROCEDURES
Chemicals/Enzymes—Trizma base, L-arginine, cytochrome c
(horse heart), K3Fe(CN)6, and other basic chemicals were
obtained from Sigma. NADPH was purchased from Alexis (San
Diego, CA). Tetrahydrobiopterin was from Research Biochemicals International (Natick, MA) or from Sigma. PfuTurbo
polymerase and XL10 Gold Escherichia coli cells were purchased from Stratagene (La Jolla, CA). Restriction enzymes
NOVEMBER 10, 2006 • VOLUME 281 • NUMBER 45

were from either Promega (Madison, WI) or New England Biolabs (Beverly, MA).
DNA Primers and Sequencing—Synthesis of all the nucleotide primers and sequencing of all clones were performed in the
Center for Advanced DNA Technologies at the University of
Texas Health Science Center at San Antonio, an institutional
core facility.
Site-directed Mutagenesis—eNOS S942A and S942T were
created by a three-primer technique, where a primer containing
the desired mutation is phosphorylated and incorporated during PCR amplification (25). The mutational primers were phosphorylated during synthesis: upstream, aca tct tca gcc ccc aaa
cgg a; downstream, tgg ttg ccat agt gac atc. Phosphorylated
primers were gca gcc ccg gac tac act gtc agc tcg gcc ccc aac gcc
ca (S942T) and gca gcc ccg gac tac gct gtc agc tcg gcc ccc aac gcc
ca (S942A).
A polymerase chain reaction was carried out using three
primers (upstream, downstream, and phosphorylated primers)
and Bov-eNOSpCW as template (26). The 1.2-kb PCR-amplified product, which contained two unique restriction sites,
KpnI and XhoI, and the desired mutation, was gel-purified. In
two independent reactions, this gel-purified 1.2-kb DNA piece,
along with Bov-eNOSpCW, was digested with KpnI and XhoI.
The larger piece from eNOS plasmid digestion was purified
from a 1% agarose gel and ligated with the digested 1.2-kb PCR
fragment. The ligated product was transformed into E. coli
XL10 Gold cells (Stratagene) and grown on LB agar plates containing 50 g/ml ampicillin. Preliminary screening was done by
restriction digestion, and the mutations were confirmed by
DNA sequencing. The plasmid containing the desired sequence
was then transformed via electroporation into E. coli BL21 cells
for protein expression.
nNOS S1176A and S1176T were produced by two sequential
PCR amplifications. Two complementary primers were
designed containing the codon for the desired mutations. Two
additional primers, sense and antisense, were designed to
amplify the entire nNOS coding region of nNOSpCW (27),
including the restriction sites NdeI and XbaI, at the 5⬘ and 3⬘
end, respectively. In the first PCR amplification, the 5⬘ and 3⬘
regions were amplified separately, using the nNOSpCW as a
template, with one middle primer and one end primer. The
middle primer contained the codon for the desired mutation. In
the second PCR, products of the first PCR amplification were
used as templates, and the end primers were used, incorporating NdeI and XbaI sites for insertion into the pCW vector. The
second PCR product was digested with NdeI and XbaI before
ligating to the pCWori vector digested with the same restriction
enzymes. The ligated product was transformed into E. coli
XL10 Gold cells (Stratagene) and grown on agar plates containing 50 g/ml ampicillin. Mutations were confirmed by DNA
sequencing. The plasmid containing the desired sequence was
then transformed via electroporation into E. coli BL21 cells for
protein expression.
First PCR—nNOS 5⬘ region amplification primers were as
follows: sense/upstream primer (NdeI restriction site), gca tgc
cat atg gct gaa gag aac acg ttt ggg; downstream (middle primer
containing the mutational codon), S1176T (gga gct gat ggt gta
gta gcg agg ctg cag) and S1176A (gga gct gat ggc gta gta gcg agg
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Ca2⫹/CaM. These findings suggest that electron flux is regulated to a large extent by various intrinsic elements present in
the reductase domain of the NOSs.
Initially, the structure of the soluble portion of CYPOR,
which possesses ⬃50 – 60% sequence similarity with the NOS
reductase domains, presented a prototype for the overall folds
of the reductase domains and the relative positioning of FAD,
FMN, and NADP(H) in these NOS isoforms (16). The solution
of crystal structures of a fragment of the nNOS reductase
domain, containing the NADPH binding site and the connecting/FAD binding domain (17), and the nNOS reductase
domain, containing both FAD and FMN binding domains (18),
demonstrated that the three-dimensional folds of the nNOS
reductase domain and CYPOR are highly conserved. The similarities of the NOS reductase domains and CYPOR, as well as
their general electron transferring properties, permitted predictions of important amino acid residues in the NOSs based on
their importance in CYPOR (19 –23). For example, mutation of
serine 457 of rat CYPOR inhibits the rate of electron transfer
from CYPOR to external electron acceptors, such as cytochrome c, and affects the redox potentials of the bound flavins
(22). This serine, which is located near the FAD in both nNOS
and CYPOR, within hydrogen bonding distance of the isoalloxazine ring, is conserved across flavoprotein reductases (24). In
the present study, the homologous serine residues of both
nNOS (Ser-1176) and eNOS (Ser-942) have been mutated to
either threonine or alanine in an attempt to understand the role
of hydrogen bonding by this residue in electron transfer and its
effect on redox potentials in the cNOSs (nNOS and eNOS). Due
to the autoregulatory inserts in the sequences of the NOS flavoprotein domains and the role of Ca2⫹/CaM for the activities,
the consequences of such substitutions could not be assumed to
be predictable. Substitution of serine by threonine was chosen
because the threonine residue has an additional methylene
group as compared with serine but retains the -OH group and,
thus, may not disrupt the hydrogen bonding network in the
region. With the alanine substitution, however, disruption of
the hydrogen bonding network occurs, since alanine lacks the
-OH group. Substitution of serine by either alanine or threonine in nNOS and eNOS inhibited the rate of reduction of both
potassium ferricyanide and cytochrome c. On the other hand,
the threonine mutants of both nNOS and eNOS showed equal
or slightly increased NO production as compared with the wild
type protein. The redox potentials of different redox centers of
wild type and mutant proteins were also measured, and differences were found for the alanine-substituted proteins but not
for the threonine mutant as compared with the respective wild
type proteins. The implications of these results in the overall
mechanisms of the constitutive NOS isoforms are discussed.

Role of Conserved Serine in Constitutive NOS Isoforms
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mM for each rate calculation. The measured turnover numbers
were plotted against the concentrations of K3Fe(CN)6, for
determination of Km for ferricyanide, and the turnover number
was determined by fitting the data using the Michaelis-Menten
equation. All steady-state spectrophotometric measurements
were performed on a Shimadzu model 2401PC UV-visible dual
beam spectrophotometer.
Rapid Kinetics Measurement of Flavin Reduction—The rate
of flavin reduction was measured as described (34) using an
Applied Photophysics SX.18MV stopped-flow spectrophotometer. Measurements were carried out using 2 M enzyme, 100
M NADPH, without or with 10 M calmodulin, and an excess
of CaCl2 in 50 mM Tris/HCl, pH 7.4, and 100 mM NaCl. The rate
of flavin reduction was monitored at 485 nm for 0.5 or 2.0 s, and
the reduction rates were calculated by fitting the data to a double exponential equation, which fitted the rate data best, using
vendor-supplied software. The rates are expressed as s⫺1.
Nitric Oxide Formation—The rate of NO production was
measured as the rate of formation of methemoglobin from oxyhemoglobin upon the binding of NO, as described (35). The
reaction mixture contained 8 M oxyhemoglobin, 100 M L-arginine, 5 M tetrahydrobiopterin, 100 M NADPH, 25–50 nM
enzyme, 187.5–375 nM calmodulin, and 200 M CaCl2 in 50 mM
Tris/HCl, pH 7.4, and 100 mM NaCl. The reaction was monitored as a change in absorbance at 401 nm, and rates were
calculated using the extinction coefficient 60 mM⫺1 cm⫺1.
Potentiometric Titrations—Redox titrations for both the wild
types and their mutant enzymes were carried out as described
by Dutton (36). All titrations were performed under nitrogen in
a cuvette modified to accommodate the platinum/calomel
combination reference electrode, which did not interfere with
spectral measurements. All potentiometric experiments were
performed at room temperature (23 °C as measured in the spectrophotometer). These titrations necessitate the repetitive
removal of the cuvette from the instrument as each aliquot of
reductant is delivered and subsequent mixing of the dyes on a
miniature stir plate. Dye mediators used were methyl viologen
(5 M), benzyl viologen (5 M), safranine o (2 M), anthroquinone-2-sulfonate (10 M), anthroquinone 2,6-disulfonate (10
M), resorufin (2 M), phenazine (5 M), and 1,4-hydroxynaphthoquinone (5 M) with dithionite as the reductant and potassium ferricyanide as the oxidant. Titrations of optical bands
were simulated using the equations described by Gao et al. (37)
and Dunford et al. (38).
Simulation of the optical bands was carried out by using
summed contributions from heme states (two states) and flavin
states (six states). At a given wavelength, these contributions
are of the following form.
A heme ox ⫽ Cheme ⫻ ⑀heme ox
⫻ 10共Eh ⫺ Emheme兲 F/RT/共1 ⫹ 10共Eh ⫺ Emheme兲 F/RT兲 (Eq. 1)
A heme red ⫽ Cheme ⫻ ⑀heme red
⫻ 10共Eh ⫺ Emheme兲 F/RT/共1 ⫹ 10共Eh ⫺ Emheme兲 F/RT兲 (Eq. 2)
A FAD ⫽ CFAD ⫻ ⑀FAD ⫻ 1/共1 ⫹ 10共Eh ⫺ E1FAD兲 F/RT
⫹ 10共Eh ⫺ E1FAD兲 F/RT10共Eh ⫺ E2FAD兲 F/RT兲 (Eq. 3)
VOLUME 281 • NUMBER 45 • NOVEMBER 10, 2006
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ctg cag). NOS 3⬘ region amplification primers were as follows:
upstream (middle primer containing the codon for desired
mutation), S1176T (cgc tac tac acc atc agc tcc tct cag ac) and
S1176A (cgc tac tac cgc atc agc tcc tct cag ac); antisense/downstream primer (XbaI restriction site), atg cat tct aga tta gga gct
gaa aac ctc atc.
Second PCR—Sense/upstream primer (NdeI restriction site)
was gca tgc cat atg gct gaa gag aac acg ttt ggg. Antisense/downstream primer (XbaI restriction site) was atg cat tct aga tta gga
gct gaa aac ctc atc.
Protein Expression and Purification—All the NOSs (wild type
and mutants) were purified as published (26, 27). Calmodulin
was expressed and purified according to Zhang and Vogel (28).
Measurement of Heme and Flavin Content—The total heme
content was measured by the pyridine hemochromogen
method as previously described (29, 30). In short, the protein
was incubated in 0.1 N NaOH and 30% pyridine, and the pyridine hemochromogen spectrum was obtained. Concentration
of heme was calculated using the extinction coefficient, ⑀ ⫽ 34
mM⫺1 cm⫺1 at 556 nm.
The FAD and FMN contents of wild type and mutant proteins were measured as described by Faeder and Siegel (31). In
short, known amounts of protein samples were boiled for 5 min
and centrifuged for 10 min to pellet the precipitated protein.
Aliquots of supernatant, which contained FAD and FMN, were
taken, and the fluorescence was measured at two different pH
states to differentiate between the flavins. Concentrations of
FAD and FMN were calculated by comparison with standard
curves, as described (31). The flavin content of these enzymes
was also measured using a high pressure liquid chromatography method. Samples were diluted to a final concentration of 1
M in distilled H2O and boiled for 5 min and spun for 10 min at
high speed before injecting into a C18 column under isocratic
flow of 10 mM (NH4)2HPO4, pH 5.5, and CH3CN in a ratio of
100:12. The FAD and FMN contents were determined by comparing the percentage of area under the peak with the standards
(32).
Reductase Activities—Cytochrome c reduction by these proteins was measured as described by Masters et al. (33) with
modification. In short, the rate of cytochrome c reduction
was measured as the rate of increase in absorbance at 550 nm
using the molar extinction coefficient 21 mM⫺1 cm⫺1. The
reaction was performed in 50 mM Tris/HCl buffer, pH 7.4,
with 100 mM NaCl and 40 M cytochrome c, 10 –50 nM
enzyme, a 5–7.5-fold molar excess of CaM to the enzyme,
200 M CaCl2, and 100 M NADPH. The reactions were
monitored for 30 s, and the initial rates were plotted. Determination of Km for cytochrome c involved variation of cytochrome c concentration from 1 to 50 M. The range of
NADPH concentration used was 250 nM to 50 M for the Km
determination of NADPH, keeping the cytochrome c concentration at 40 M.
Potassium ferricyanide (K3Fe(CN)6) reduction was measured as the rate of decrease in absorbance at 420 nm over 30 s,
using a molar extinction coefficient of 1.02 mM⫺1 cm⫺1. The
amounts of enzyme, calmodulin, and NADPH used were the
same as those used in the cytochrome c reduction assays. The
concentration of K3Fe(CN)6 used was varied from 0.025 to 3.0

Role of Conserved Serine in Constitutive NOS Isoforms
A FADH䡠 ⫽ CFAD ⫻ ⑀FADH䡠 ⫻ 10共Eh ⫺ E1FAD兲 F/RT/共1 ⫹ 10共Eh ⫺ E1FAD兲 F/RT
⫹ 10共Eh ⫺ E1FAD兲 F/RT10共Eh ⫺ E2FAD兲 F/RT兲 (Eq. 4)
A FADH2 ⫽ CFAD ⫻ ⑀FADH2
⫻ 10共Eh ⫺ E1FAD兲 F/RT10共Eh ⫺ E2FAD兲 F/RT/共1 ⫹ 10共Eh ⫺ E1FAD兲 F/RT
⫹ 10共Eh ⫺ E1FAD兲 F/RT10共Eh ⫺ E2FAD兲 F/RT兲 (Eq. 5)
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FIGURE 1. Sequence alignments. The accession number of each protein is
given in italics within parentheses after each protein along with the relevant
reference. Amino acid sequences of rat nNOS (P29476) (10), bovine eNOS
(P29473) (56), macrophage iNOS (NP_035057) (57), CYP 102 (BM3) (AAA87602)
(58), CYPOR (NP_032924) (59), rat cytochrome b5 reductase (NP_620232) (60),
ferredoxin reductase (spinach FNR) (P00455) (51), human methionine synthase reductase (NP_076915) (61), tobacco nitrate reductase (CAA32217) (62),
E. coli sulfite reductase (BAB37042) (63), human NADPH oxidase (NP_008983)
(64), and yeast ferric reductase (NP_012702) (65) were aligned using Bio-edit.
Approximately 20 C-terminal amino acids of nNOS and the corresponding
residues of other isoforms around the conserved serine residue (shown boldface type) are shown for clarity. ⬃ and 䡠, gaps during alignment.

RESULTS
Sequence Alignments and Structure Showing nNOS Ser-1176—
The reductase domains of NOSs are members of the FAD/
FMN-containing flavoprotein family with ⬃55% sequence similarity to CYPOR (10). The most conserved regions of this
family of proteins are the NADPH-, FAD-, and FMN-binding
sites (16). Fig. 1 shows a partial amino acid sequence alignment
among the reductase domains of rat nNOS, bovine eNOS, macrophage iNOS, Bacillus megaterium CYP102 (P450 BM3), and
other flavoproteins. A serine residue in the FAD binding
domain (boldface type in Fig. 1) is one of the conserved residues
in the flavoprotein family. Mutational studies of this conserved
serine residue have been carried out for several of these flavoproteins. In the case of FNR, this conserved serine residue is
primarily involved in hydride ion transfer by affecting the interaction between the nicotinamide ring of NADP⫹ and FAD (39).
In cytochrome b5 reductase, the threonine residue at this position plays an important role in catalysis and electron transfer
(40). The intricate hydrogen bonding network of this serine
residue, along with conserved cysteine, aspartate, and tryptophan residues in CYPOR (16), has been implicated in hydride
ion transfer in CYPOR (41).
Based on the crystal structures of the nNOS reductase
domain and a fragment containing the NADPH- and FADbinding domains, Ser-1176 of nNOS is near the N5 atom of the
isoalloxazine ring of FAD (3.7 Å) and within hydrogen bonding
distance of the FAD O4 atom (17, 18) (Fig. 2), suggesting a
mechanistic role for this residue in NOSs also. Since electron
flow through the reductase domain in the NOSs is regulated by
CaM binding and by intrinsic protein elements, unlike any of
the other flavoproteins listed, the role of this serine residue may
be different or more complex (42). We mutated this conserved
serine in both nNOS and eNOS to threonine, which appears in
some flavoproteins at this site (Fig. 1), and to alanine.
To ascertain whether the purified mutant proteins were as
stable as their wild type counterparts and contained similar
amounts of prosthetic groups, the absolute spectra were compared, and heme and flavin contents of these proteins were
JOURNAL OF BIOLOGICAL CHEMISTRY
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The value of RT/F at 25 °C is ⬃59.6 mV, and A represents the
absorbance of different components. ⑀ represents the extinction coefficient of the various redox states, with the subscript
designating the redox state of a redox center. Variables of the
form Cheme represent the total concentration of heme, which
includes all of the redox and spin states (or, equivalently, flavin).
These states are in rapid equilibrium during the time scale of
redox equilibration in the experiment. Eh is the standard potential relative to the hydrogen electrode as measured potentiometrically. Emheme, E1FAD, and E2FAD are the midpoint potentials of the one-electron couples. E1 and E2 are the midpoint
potentials for the first and second one-electron reduced states.
The absorbances associated with different redox states of FMN
during titration are obtained by simply substituting FMN in
place of FAD in Equations 3–5. In some cases, multiple heme
components that differ in concentration, extinction coefficient,
and midpoint potential have been introduced for simulation
purposes.
Pure dye spectra were subtracted from the experimental
spectra to derive the true change in the absorbance during titration. Spectra were further normalized for dilution and corrected for base line. Corrected absorbance at a given wavelength is plotted against the potential. Wavelengths were
chosen at which the extinction coefficients of species of interest
are dominant while other states are negligible. Theoretical
curves were generated by manipulating parameters, such as
midpoint potential (Em) for each chromophore and amplitude,
a term that includes both enzyme concentration and extinction
coefficient at the corresponding wavelength, in each equation
to fit the experimental data. For the simulation, the same
extinction coefficient for FAD and FAD semiquinone and a 1:2
heme/flavin ratio were assumed. A value for the potential is
accepted as the determined value when simulations at different
wavelengths yield the same set of potentials.
The possibility of assigning more than one redox state to the
data at a particular wavelength and the instability of some redox
states that reduces the accumulation of the chromophore lead
to uncertainty in the determination of some potentials; however, the confidence level of such assignments is determined
from data at different wavelengths.
Flavin Reduction and Reoxidation—The reoxidation of flavin
was monitored as a change in absorbance at 485 nm in the
presence of 1 M enzyme, 100 M NADPH, without or with
Ca2⫹/CaM, in 50 mM Tris/HCl, pH 7.4, buffer, containing 100
mM NaCl. The reaction was initiated with fully oxidized
enzyme, and NADPH was added after 60 s of monitoring the
absorbance. The reaction was continued until no further net
change in absorbance was observed (12, 13).

Role of Conserved Serine in Constitutive NOS Isoforms
the rate of electron flow from NADPH through FAD, since
potassium ferricyanide accepts electrons directly from FAD,
analogous to CYPOR (42– 45).
Cytochrome c Reduction—Comparison of the rate of reduction of cytochrome c by nNOS and eNOS and their S1176T and
S1176A mutants is shown in Fig. 4a. In the case of nNOS
S1176T, the rate of cytochrome c reduction is decreased ⬃7–
8-fold in the absence of Ca2⫹/CaM (470 versus 60 min⫺1) and is
similarly decreased ⬃7– 8-fold in the presence of Ca2⫹/CaM
(4777 versus 704 min⫺1) as compared with that of wild type.
The nNOS S1176A mutation lowered the rate of cytochrome c
reduction 13-fold in the absence of Ca2⫹/CaM (470 min⫺1 versus 36 min⫺1) and 36-fold in the presence of Ca2⫹/CaM (4777
versus 156 min⫺1) in comparison with wild type protein.
The rate of electron transfer by eNOS is the slowest among
the three NOS isoforms (46). Substitution of threonine for Ser942 lowered the rate of electron transfer to cytochrome c
⬃2-fold both in the absence (243 versus 123 min⫺1) and presence of Ca2⫹/CaM (762 versus 431 min⫺1) (Fig. 4a). The S942A
substitution of eNOS inhibited the rate of cytochrome c reduction 10.5-fold in the absence (243 versus 23.2 min⫺1) and
⬃7-fold in the presence of Ca2⫹/CaM (762 versus 111 min⫺1).
Despite the fact that the threonine mutants showed a net
decrease in the rate of cytochrome c reduction both in the
absence and presence of Ca2⫹/CaM, the stimulation of the
reductase activity upon the addition of Ca2⫹/CaM was
the same as that of the wild type enzymes, which was not the
case with alanine mutants.
The Km values for cytochrome c for mutants were comparable with the wild type proteins (⬃3 M), which suggests that the
attenuation in the rate of cytochrome c reduction was not
caused by alteration of cytochrome c interaction. Similarly, little or no difference was observed in the Km value for NADPH
between wild type and mutants of either nNOS or eNOS (0.150.5 M), suggesting that the decrease in the reductase activity
cannot be attributed to it.
FIGURE 2. Partial structure of nNOS reductase domain. The figure shows
Potassium Ferricyanide Reduction—The decreased rate of
Ser-1176 in blue, Asp-1393 and Phe-1395 in red, and space-filled FAD in yellow cytochrome c reduction implied that the electron flow to FMN
and partial backbone structure associated with these amino acids. The carbon backbone chain is shown as flat ribbons; blue is in the si-face, and red is in was decreased as compared with the wild type protein. This
the re-face of the FAD. The partial backbone structure was shown in order to inhibition of electron flow may occur at one or more of the
illustrate the bonding pattern between Ser-1176 and Asp-1393 of two different backbone chains. Inset, nNOS reductase domain structure (17, 18) span- following steps: NADPH 3 FAD, FAD 3 FMN, or FMN 3
cytochrome c. To determine whether the mutations affect elecning residues 963–1407.
tron transfer through FAD from
NADPH, the rate of potassium ferricyanide reduction was measured
for wild type proteins and for all of
the mutants, since potassium ferricyanide can accept electrons from
FAD (Fig. 4b). In the case of nNOS
S1176T, a ⬃5-fold decrease from
wild-type was observed in the
absence of Ca2⫹/CaM (wild type
rate 38,000 min⫺1 versus mutant
rate 7800 min⫺1), and a similar -fold
decrease (⬃5-fold) was observed in
the presence of Ca2⫹/CaM (wild
FIGURE 3. Absolute spectra of NOSs. The figure shows the absolute spectra of both nNOS and eNOS wild type
⫺1
versus
(wt) (solid line) and their serine to threonine mutants (dashed line) and serine to alanine mutants (dotted line) for type activity 48,000 min
comparison.
mutant activity 9400 min⫺1). A
measured. All of the mutants contained amounts of heme,
FAD, and FMN comparable with those of the wild type proteins
and showed no differences in their absolute spectra (Fig. 3).
Reductase Activities of NOSs Using External Electron Acceptors—The location of this serine residue near the FAD in NOS
isoforms and its putative participation in a hydrogen bonding
network make it a good candidate for a role in electron transfer.
To determine its influence on electron shuttling within the
reductase domain, the rates of electron transfer to external
acceptors, such as cytochrome c and potassium ferricyanide,
were measured for the wild type proteins and compared with
the threonine and alanine mutants. These measurements
reflect the rate of electron transfer in the reductase domain
from NADPH through FAD to FMN or through FAD alone,
depending upon the specific acceptors involved. Cytochrome c
reduction measures the rate of electron transfer through the
entire reductase domain, since this acceptor receives electrons
from FMN. Potassium ferricyanide reduction primarily reflects
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tution showed a much larger
decrease in the activity as compared
with the threonine substitution. In
the absence of Ca2⫹/CaM, the
eNOS S942A mutant showed a
⬃14-fold decrease in the K3Fe(CN)6
reduction (wild type rate 17,000
min⫺1 versus mutant rate 1200
min⫺1) and ⬃20-fold decrease in
the presence of Ca2⫹/CaM (wild
type rate 30,000 min⫺1 versus
mutant rate 1400 min⫺1) as compared with the wild type activity. For
nNOS WT, the Km for ferricyanide
was determined to be 1–1.5 mM,
similar to that reported by Roman
et al. (42) for S1176T, 0.5–1.0 mM,
and for S1176A, 0.3– 0.7 mM. However, the apparent Km values for ferricyanide for eNOS wild type and
the mutants were lowered compared with the nNOS and the
FIGURE 4. Reductase activities of wild-type nNOS, wild type eNOS, and serine mutants. a, cytochrome c
reductase activity. Turnover numbers for cytochrome c reduction were measured using 20 nM (nNOS) or 50 nM mutants. For eNOS wild type, the
(eNOS) of enzyme, both in the absence and presence of Ca2⫹/CaM as described under “Experimental Proce- Km for ferricyanide was 0.4 – 0.6
dures.” The open bars represent rates in the absence of Ca2⫹/CaM, and filled bars show rates in its presence.
Data shown represent the average of three or more independent experiments performed with two or more mM, for S942T, it was 0.25 mM, and
independent protein purifications. The wild type (wt) and mutant proteins for each isoform were expressed for S942A, it was 0.05 mM. In sumand purified simultaneously to minimize errors between purifications. b, potassium ferricyanide reduction. mary, the decrease in the rate of
Rates of potassium ferricyanide reduction were measured using 20 nM (nNOS) or 50 nM (eNOS) enzyme, both in
the absence and presence of Ca2⫹/CaM as described under “Experimental Procedures.” Open bars, rates in the potassium ferricyanide reduction
absence of Ca2⫹/CaM; filled bars, rates in its presence. Data shown represent the average of three or more for nNOS and eNOS resulting from
independent experiments performed with two or more independent protein purifications. The wild type and both alanine and threonine substimutant proteins for each isoform were expressed and purified simultaneously to minimize errors between
tutions implies that the mutation of
purifications.
the serine spatially contiguous to
FAD affects electron transfer from NADPH to/from FAD.
NO Production—Substitution of serine with threonine or alanine inhibited the rate of electron flow through the flavin
domain as seen by the reduction of external electron acceptors,
such as cytochrome c and ferricyanide, which are not the physiological partners. To determine the effect of the mutation on
enzymatic activity, which involves transfer of electrons to the
heme domain, the rate of NO production by these mutants was
FIGURE 5. Rate of nitric oxide production by wild-type nNOS and eNOS measured and compared with that of the wild type enzymes
and their serine mutants. Rates of NO production were measured as (Fig. 5). The rate of NO production in the serine to alanine
described under “Experimental Procedures” using the hemoglobin capture mutation, in both nNOS and eNOS, is significantly lower than
assay. Data shown represent the average of three or more independent
experiments done with two independent protein purifications. The wild type that of the wild type proteins. The alanine substitution reduced
(wt) and mutant proteins for each isoform were expressed and purified simul- the rate of NO production by 2.7- and 4.7-fold for nNOS and
taneously to minimize the error between purifications. **, p ⬍ 0.05 was
eNOS, respectively. However, when serine was replaced with
obtained for eNOS S942T compared with the eNOS wt (the p value was deterthreonine, an equal or a slightly higher rate of NO production
mined from two-tailed Student’s t test).
was consistently observed for both nNOS and eNOS in multiple
much larger diminution in the activity was measured in the case preparations.
Rapid Kinetics Measurement of Flavin Reduction—To examof nNOS S1176A. A ⬃22-fold decrease from the wild type activity was observed for nNOS S1176A in the absence of Ca2⫹/CaM ine the effect of these mutations on the initial rate of flavin
(37,800 min⫺1 versus mutant activity 1700 min⫺1), and a ⬃20- reduction, the rates for both wild type and mutant proteins
fold decrease in the presence of Ca2⫹/CaM (48,000 min⫺1 ver- were measured using stopped-flow spectrophotometry (Fig. 6).
sus mutant activity 2400 min⫺1) was observed. In the case of the The kinetic traces of flavin reduction can be fitted to either a
eNOS S942T mutation, the measured activity in the absence of biphasic or a triphasic equation within the measured time
Ca2⫹/CaM was ⬃6-fold less than the wild type eNOS activity frame (0.5 or 2 s), consistent with published work (34, 47).
As previously pointed out, observed changes in the rapid
(17,000 versus 2900 min⫺1) and ⬃5.5-fold less in the presence
of Ca2⫹/CaM (30,000 versus 5600 min⫺1). The alanine substi- kinetics of NOS flavin-mediated electron transfer represent
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FIGURE 6. Rapid kinetics measurements for wild type nNOS and its serine
mutants. The traces show the rapid kinetics measurements for nNOS wild
type and its threonine and alanine mutants in the presence and absence of
Ca2⫹/CaM. The measured data (rough line) was fitted (smooth line) to a double
exponential equation using the vendor-supplied program. Each trace is an
average of three independent measurements.

942 residue to threonine or alanine were observed (data not
shown).
Redox Potential Measurements—To probe the underlying
mechanism of the role of the serine in the FAD domain, midpoint potentials were measured for various flavin redox states
(Table 2). Fig. 7a shows the changes in absorbance of nNOS
S1176T and S1176A at 600 and 650 nm at various potentials
during titration. This wavelength region was chosen, since it
contains information regarding all five one-electron Em values
due to flavin semiquinones and high spin ferriheme (37, 48).
Simulations were performed to obtain the midpoint potential
of these states (Fig. 7a, lower panels). Similarly, Fig. 7b shows
the change in absorbance of eNOS S942T and S942A during
titration at 600 and 650 nm. Simulation of titration spectra at
other wavelengths was also generated as shown in Fig. 8. Shown
in Fig. 8a are actual spectra obtained with nNOS S1176T (360 –
440 nm). Fig. 8b shows the absorbance changes as a function of
changes in potential plotted as an increase at 390 nm and a
decrease at 414 nm. Fig. 8c shows the simulated data for various
flavin redox state components of nNOS S1176A obtained at 480
nm. These three different wavelengths were chosen to further
support the potentials generated by simulations performed at
600 and 650 nm (Table 2). First of all, the heme Soret band was
chosen to confirm heme potentials. All four mutants showed
very similar Soret band signatures (Fig. 8a). The shift of the
Soret peak from 414 to 390 nm can be clearly observed as
the enzyme reoxidizes, and the plot of peak heights at these
wavelengths confirms the single component Em for heme to be
around ⫺300 mV. It is worth mentioning that although oxidized and reduced flavins have optical contribution in the Soret
region, the contribution of heme is dominant. At 414 nm,
almost the entire change is due to the formation of ferroheme,
whereas at 390 nm, reduction of FMN contributes to the spectrum of wild type enzyme at high potential, and reduction of
FAD contributes at potentials where the heme redox state is
changing. Verification of flavin potentials was done by simulations at 480 nm, a region on the shoulder of the heme Soret, but
with flavin species responsible for most of the optical changes.
Using nNOS S1176A as an example, the intensity of the 480 nm
band was simulated with contributions from oxidized flavins,
and the blue neutral semiquinones of both FAD and FMN (Fig.
8c). For both the nNOS and eNOS alanine mutants at this position, the FAD semiquinone is too unstable to allow the determination of individual one-electron potentials and can be omitted from the simulations. Although the semiquinone of FAD
(dashed line) cannot be readily monitored, the formation of
oxidized FAD (dashed and dotted line) was visible together with
the stabilized FMN semiquinone (dotted line), allowing the

TABLE 1
Rapid kinetic measurement of flavin reduction
Rates are measured in s⫺1. The values within parentheses indicate the percentage contribution of the fast and slow phases of the kinetics.
Enzyme

Without Ca2ⴙ/calmodulin
Fast phase

Slow phase

With Ca2ⴙ/calmodulin
Fast phase

s⫺1

nNOS wild type
nNOS S1176T
nNOS S1176A

57.4 ⫾ 0.7 (51%)
15.5 ⫾ 3.6 (30%)
3.9 ⫾ 0.6 (33%)
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Slow phase
s⫺1

4.95 ⫾ 0.45 (49%)
2.02 ⫾ 0.4 (70%)
0.9 ⫾ 0.1 (67%)

293 ⫾ 30 (53%)
13.8 ⫾ 0.3 (46%)
6.2 ⫾ 0.4 (48%)

31.05 ⫾ 6.55 (47%)
9.7 ⫾ 0.77 (54%)
1.8 ⫾ 0.1 (52%)
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transitions between pathway segments composed of states in
rapid equilibrium, not transitions between individual states
(47). The initial rapid phase of flavin bleaching corresponds to
loss of 485 nm absorbance due to the establishment of rapid
equilibrium between the initial NADPH complex of the oxidized enzyme, the FAD charge transfer complex with NADPH,
and the FADH2 state with NADP⫹ bound.
The data clearly show that both the S1176T and S1176A
mutants have markedly slower rates of reduction by NADPH in
comparison with wild type nNOS in the presence and absence
of Ca2⫹/CaM (Table 1). In both cases, the slower rates are likely
to be associated with processes limited or gated by the binding
and release of pyridine nucleotides (see “Discussion”) and cannot be solely attributed to the altered thermodynamics of redox
reactions.
Furthermore, unlike the fast phase of reduction of wild type
nNOS, the fast phase of both the serine mutants is at most
minimally influenced by Ca2⫹/CaM activation. In contrast, the
slow phase of S1176T is stimulated to a similar degree as wild
type, but S1176A shows a modest 2-fold increase. Similar
effects with wild type eNOS and mutations of the cognate Ser-
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TABLE 2
Midpoint potentials of different redox centers

nNOS wild type
nNOS S1176T
nNOS S1176A
eNOS Wild type
eNOS S942T
eNOS S942A

FMN ox/sq

FMN sq/hq

FAD ox/sq

FAD sq/hq

Heme single

Heme high

mV

mV

mV

mV

mV

mV

mV

⫺120
⫺120
⬎40a
⫺105
⫺100
⬎80a

⫺220
⫺220
⫺240
⫺240
⫺240
⫺230

⫺250
⫺240

⫺260
⫺300

⫺290
⫺300
⫺290
⫺280
⫺280
⫺280

⫺250

⫺350

⫺260

⫺350

⫺230
⫺230

⫺205b
⫺200

b

⫺260
⫺240

Heme low

a

Values signify positive potentials out of the mediated titration region.
b
Due to the unstable FAD semiquinone in the alanine mutants, the FAD ox/sq state cannot be monitored clearly in order to give accurate individual FAD potentials. Since
FADH2 oxidation can be successfully simulated by treating it as a 2e⫺ process; the 2e⫺ value is given.

DISCUSSION
Evolution of FAD and FMN binding sites has allowed development of unique catalytic properties in electron transferring
enzymes (49, 50). Flavin cofactors often participate in intricate
hydrogen bonding systems. Conserved hydrogen bonding networks involving serine (Ser-457 of rat CYPOR, Ser-1176 of rat
nNOS), aspartate (Asp-675 of CYPOR, Asp-1393 of nNOS),
and cysteine (Cys-630 of CYPOR, Cys-1349 of nNOS) flank
FAD in NOS and CYPOR (Fig. 2) (16 –18). Ser-1176 is within
NOVEMBER 10, 2006 • VOLUME 281 • NUMBER 45

hydrogen bonding distance of N5 and O4 of FAD and Asp1393. A hydride transfer mechanism for CYPOR and homologues has been proposed, envisioning important roles for the
serine OH group and its neighbors. Ser-457 of CYPOR (22) and
Ser-96 in ferredoxin-NADP⫹ reductase (39) (FNR) were implicated in hydride transfer. Ser-457 mutants of CYPOR have low
electron transfer rates to external acceptors, but Km values for
NADPH are normal.
Here we studied the role of nNOS Ser-1176 and its eNOS
cognate, Ser-942, by mutation to threonine or alanine. Flavin
reduction rates and redox potentials were affected, and
K3Fe(CN)6 and cytochrome c reduction were impaired. In
stopped-flow experiments, both major phases of flavin absorbance changes are slower in the mutants.
Knight and Scrutton (47) pointed out difficulties in assigning
kinetics phases in stopped flow experiments to specific processes, assigning phases to rapid equilibrium segments rather
than specific states. These phases are likely to be limited by
pyridine nucleotide binding/release and/or associated local
conformational changes, which gate electron transfer processes. Their uncoupling of kinetic phases from FAD and FMN
reduction is an important contribution.
The majority of the 485 nm absorbance change is most likely
due to the conversion of FAD to the charge transfer complex
and the reduced state, both of which are reflected in the phase I
rate in Table 1, whereas the second or subsequent kinetic
phases probably reflect shifts in component equilibria.
Both S1176T and S1176A exhibit slower rates of phase I conversion. Midpoint potential alone cannot account for this, since
the reduction of FAD by NADPH is favorable. The limiting
process thus cannot be only electron transfer, and the disruptive nature of the mutants suggests that it is also the formation
of the charge transfer complex with the NADPH. In wild type
nNOS, calmodulin affects both the initial phase, limited by
NADPH binding, and the second slower phase, probably limited by NADP⫹ release or internal processes, such as conformational changes (52). It is conceivable that disruption of the
precise environment and the precise hydrogen-bonding network by substitution of threonine or alanine for serine alters
binding and release of pyridine nucleotides; our results further
indicate that this also negates the effect of Ca2⫹/CaM on the
initial binding of NADPH.
The structural basis for the altered kinetics has several components. The alanine mutants lose side chain hydrogen bonding to N5 of FAD, and potential backbone hydrogen bonding is
JOURNAL OF BIOLOGICAL CHEMISTRY
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measurement of the two-electron potential for FAD; the first
one-electron reduction of FAD must be at least 60 mV more
negative than the second one-electron reductive step. The oxidized FMN is not shown in the simulation due to the very high
potential for the FMN/FMNH䡠 transition. Similar transitions
were also observed in the simulation of the 650 nm band (Fig.
7a). These data are in complete agreement with the data in
Table 2. Both nNOS and eNOS threonine mutants possess very
similar redox potentials in comparison with respective wild
types. Both of the threonine mutant simulation plots show
trends similar to that of wild type protein, as reported by Gao et
al. (37). A considerable difference was observed for the alanine
mutants of both nNOS and eNOS. Disruption of the hydrogen
bonding network near FAD by alanine increased the redox
potential of the FADH䡠/FADH2 couple ⬃50 mV. The most
striking difference was noticed for the FMN/FMNH䡠 couple for
the alanine mutant of both nNOS and eNOS, which made this
redox couple 160 and 185 mV more positive compared with the
wild type, respectively. The exact potential for the FMN/
FMNH䡠 transition in this mutant is too positive to be determined accurately using our mediated titration system. Fig. 9, a
and b, show comparative plots of midpoint potentials of the
different redox centers of wild type and mutant cNOSs. Unlike
the wild type or the threonine mutants, these plots show that
the FMN semiquinone of alanine mutants is stable even at very
high potential.
Flavin reduction by NADPH and reoxidation of the wild type
and mutant proteins were measured at 485 nm as described
earlier (12, 13). The threonine mutants of both nNOS and
eNOS clearly showed a fully reduced state, which reoxidized
gradually upon depletion of NADPH. Similar kinetics have
been reported earlier for wild type proteins (12, 13). On the
other hand, alanine mutants that cannot make some critical
hydrogen bonds demonstrated different kinetics, showing a
much less stable reduced flavin state, which reoxidized rapidly
(data not shown).
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FIGURE 7. Redox titrations of serine mutants of nNOS and eNOS. Intensities of 600 nm (f) and 650 nm (Œ) bands, during redox titration, of nNOS S1176T and
S1176A mutants (a) and eNOS S942T and S942A (b) were plotted against the potential, and data were simulated (solid line) for flavin redox states using the
Nernst equation (37). Deconvolution of nNOS S1176T and nNOS S1176A at 650 nm (a, bottom panels). Three components, the high spin ferriheme charge
transfer band (dotted line), the blue neutral semiquinones of FMN (thin dashed line), and FAD (dashed and dotted line), add up to give rise to the composite curve
(solid line), which simulates experimental data points (filled black squares) to ⫾10 –20 mV accuracy. The base line has been corrected by subtraction of the most
reduced spectrum. Fitting parameters for S1176T are as follows: FAD, Eox/sq ⫽ ⫺240, Esq/hq ⫽ ⫺300, c*⑀ ⫽ 0.02; FMN, Eox/sq ⫽ ⫺120, Esq/hq ⫽ ⫺220, c*⑀ ⫽ 0.02;
heme, Em ⫽ ⫺300, c*⑀ ⫽ 0.012; fitting parameters for S1176A are as follows: FAD, Eox/sq ⫽ ⫺240, Esq/hq ⫽ ⫺170, c*⑀ ⫽ 0.02; FMN, Eox/sq ⬎ 40, Esq/hq ⫽ ⫺240,
c*⑀ ⫽ 0.02; heme, Em ⫽ ⫺290, c*⑀ ⫽ 0.012. Deconvoluted curves for eNOS mutant simulation gave similar results (data not shown).

perturbed by disrupting the Ser-1176 –Asp-1393 side chain
hydrogen bond. Smaller rate reductions were observed in the
threonine mutants, which can still form a hydrogen bond
with the side chain of Asp-1393. Analysis of the wild type
crystal structure suggests that the space surrounding Ser1176 is sterically restricted and cannot easily accommodate
an additional methylene. To accommodate the additional
group, the local backbone and neighboring strands must be
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relaxed. Changes in the FAD environment can influence
electron transfer without compromising the structural
integrity of the protein.
Although electron transfer to external acceptors is reduced
in the threonine mutants, NO production is normal. Threonine
mutants of both nNOS and eNOS have midpoint potentials
comparable with those of wild type enzymes (Table 2). In wildtype NOS, electron transfer to the heme domain is rate-limitVOLUME 281 • NUMBER 45 • NOVEMBER 10, 2006
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ing, and apparently the conservative serine/threonine substitution does not affect the limiting step. The alanine mutant, on
the other hand, exhibits reduced NO production, indicating
that electron transfer to the heme domain is slow, as expected
from the redox potentials; the higher potential of FADH䡠/
FADH2 couple makes the reduction of the FMNH䡠 semiquinone unfavorable (Table 2).
Loss of the hydrogen bonding pattern near FAD, which plays
an important role during catalysis in CYPOR (41), appears to
influence the environment of FAD in alanine mutants and may
NOVEMBER 10, 2006 • VOLUME 281 • NUMBER 45
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FIGURE 8. Titration spectra of S1176T in the Soret region and simulation
of S1176A data at 480 nm. a, actual spectra of S1176T around the Soret
region (360 – 440 nm) at different potentials are overlaid. b, plot of the absorbance changes at wavelengths 390 nm (f) and 414 nm (Œ) versus potentials.
The lines through the data points are the simulated curves. c, absorbances at
480 nm (F) at different potentials during titration of nNOS S1176A mutant
were simulated using the redox potentials obtained from the simulations at
600 and 650 nm. The fitted line (solid line) is deconvoluted to show the contributing components, FADox (dotted and dashed line), FADsq (dashed line),
and FMNsq (dotted line).

interfere with the CaM-mediated release of the NADPH-dependent conformational lock (52). Conformational lock release
enables the FMN domain to interact with the heme domain
during catalysis, and with cytochrome c in vitro (53).
There are several mechanisms by which amino acid residues
can modify flavin electrochemistry. Ring stacking with the
shielding residue inhibits formation of the isoalloxazine chair
conformation, lowering the potentials. Hydrogen bond donors
interacting with the isoalloxazine ring generally raise the potentials, and hydrogen bond acceptor interactions lower the potentials (54). Electrostatic interactions with charged residues and
solvent interactions are additional factors.
Hubbard et al. (41) proposed a model for catalysis by
CYPOR, which invokes formation and dissociation of hydrogen
bonds to the side chain OH of serine, depending upon the redox
state of FAD and the binding of NADPH, thus cyclically altering
flavin midpoint potentials. With FAD oxidized, the Ser-457
side chain is hydrogen-bonded to Asp-675. NADPH binding
and formation of the charge transfer complex produces an
additional Ser-457 hydrogen bond with NADPH. FAD reduction severs the NADPH and Ser-OH hydrogen bond, and a
FAD/Ser-OH bond is formed. Reoxidation of FAD restores the
original state. Crystal structures of oxidized nNOS reductase
domains (17, 18) show the Ser-1176 side chain within hydrogen-bonding distance of Asp-1393, the Asp-675 cognate, but
unlike CYPOR, the Ser-1176 backbone nitrogen is also within
hydrogen-bonding distance of FAD N5.
Since the midpoint potential of the alanine mutant was raised
rather than lowered, the effects of the alanine substitution cannot be attributed to a direct interaction with the 1176 side chain
but must be the result of repositioning of the backbone, freeing
of Asp-1393, or conformational effects within the FAD site.
Increased interaction of the Ser-1176 backbone with isoalloxazine positions would be expected to favor reduced and
semiquinone states over oxidized states, as long as N5 itself is
not protonated, because of increased electron density in the
isoalloxazine ring. Loss of the Asp-1393–Ser-1176 side chain
hydrogen bond might stabilize semiquinone and reduced forms
relative to oxidized states, if the orientation of the Ser-1176
peptide nitrogen were more favorable in the mutant. The
increased midpoint potential of the FADH䡠/FADH2 is consistent with this scenario. Similar effects could also be attributed to
changes in the position of the nearby shielding residue (Phe1395) because of the loss of the Asp-1393–Ser-1176 constraint
(Fig. 2).
The alanine mutations have additional unexpected effects on
FMN, producing a higher potential nonphysiological one-electron couple (FMN/FMNH䡠) (Table 2). We initially assigned the
additional stabilized semiquinone to FAD, since the mutation
was in the FAD region. However, this assignment does not
readily account for titration of the 605 and 485 nm absorbances
and still requires that the FMN couples change to reduce the
contribution of the FMN semiquinone. Furthermore, the alanine mutants are able to transfer electrons and can undergo
catalytic turnover. A very stable FAD semiquinone would create a kinetic bottleneck, preventing electron flow from FADH䡠
to FMN; the alternative unstable FAD semiquinone produces a
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sis and may even slightly increase it.
K3Fe(CN)6 reduction decreases as
expected, because the closed (input)
conformation of the reduced enzyme
can reduce K3Fe(CN)6. An interesting
outcome of this analysis is that the
majority of solution conformational/
redox states observed during electron
transfer to K3Fe(CN)6, cytochrome c,
and the oxygenase domain for NO
production are different. Therefore, it
may be possible to trap kinetically an
intermediate of the enzyme in which
the FMN domain is neither associated with the FAD domain nor with
the oxygenase domain.
Here we have shown that the
conserved serine residue near
FAD in the constitutive NOS isoFIGURE 9. Overlay of redox potentials of NADPH, heme, and different flavin redox states of nNOS and forms plays an important role in
eNOS wild type (wt) and their serine mutants. A step graph showing the redox potentials of different redox
centers of wild type (solid line), threonine mutants (dotted line), and alanine mutants (dashed line) of both nNOS catalysis. The mutational studies
reported here and elsewhere high(a) and eNOS (b).
light differences in the microenvimuch less severe uphill step. These considerations indicate that ronment of the flavins in groups of related proteins introthe stable semiquinone is FMNH䡠. Since neither Ser-1176 nor duced during protein evolution.
Asp-1393 interacts directly with FMN, such an effect must be
transmitted through the protein to the adjacent FMN binding Acknowledgment—We thank Dr. Christopher C. Marohnic for helpful
discussions and for generating the structure figure.
site.
The altered flavin redox potentials mandate that the catalytic
cycle of the S1176A type mutants will be affected at multiple
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